Instruction for the Authors

Submit your article

Our Journal uses certified plagiarism checker softwares (iThenticate® and Grammarly®) to verify the authenticity of articles and detect duplications from each article content online against billions of web pages.


JOURNAL e-ISSN: 2379-4054

Infectious Diseases and Tropical Medicine (Infect Dis Trop Med) is a multidisciplinary, open access, peer-reviewed, online journal that publishes solicited and unsolicited articles related to the field of infectious diseases and tropical medicine, spanning from fundamental new discoveries in basic science to translational research (“bench-to-bedside”), methods and protocols, clinical trials, and identification of novel therapeutic targets. Topics covered by the journal include, but are not limited to, basic research, prevention, translational research, public health, pharmacology andpharmacogenomics aspects, treatment, elderly patients, virus-related tumors, innovative aspects regarding diagnosis, pathology, clinical-experimental infectious diseases.

Articles are posted online as soon as they have completed the production process in a fully citable form associated with a universal digital object identifier (DOI). At this time, articles are free to view and download for all.

Abstracting and Indexing


EBSCO catalogue


Cover Letter 

Authors who submit manuscripts to Infect Dis Trop Med must provide a supporting Cover Letter which briefly details the article relevance to the journal’s audience and how the article advances understanding of the field. The Cover Letter must include contact information [affiliation, postal address, e-mail address, telephone number] for all authors. Authors should indicate a Corresponding Author to whom correspondence will be sent if the manuscript is accepted for publication. In the Letter, authors must confirm that the manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere (including preprint servers). Authors must confirm that all the research meets the ethical guidelines, including adherence to the legal requirements of the study country. Authors must confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship. Cover Letter must be signed by the Corresponding Author on behalf of all the other authors.

Infectious Diseases and Tropical Medicine (Infect Dis Trop Med) publishes Editorials, Reviews, Original articles/Research articles, Brief communication, Short reports, Case reports, Case quiz and Scientific Correspondence on subjects regarding all areas of Infectious diseases: Bacterial infections, Virology, Fungal infections, Parasitology, HIV/AIDS, Antimicrobial resistance, Vaccines.

Several topics will be considered: basic research, prevention, translational research, pharmacology, and pharmacogenomics aspects, treatments, elderly patients, virus-related tumors, innovative aspects regarding diagnosis, pathology, clinical-experimental Infectious Diseases.

Infect Dis Trop Med is particularly interested in therapies and diagnostics, including all aspects of translation medicine from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses. Reviews should include systematic revision of the literature concerning the treated topics and preferably meta-analyses, original illustration and tables. Infect Dis Trop Med does not accept for the publication “data not shown” or “unpublished data”. Letters are restricted to the discussion of papers already published in the journal, with a maximum of 300 words, one table or figure and up to ten references.


Article Processing Charges (APCs)

This journal does not charge APCs or submission charges. No fee is required to publish in our Journal.


Article Types

Original Articles

Original Articles should present novel work that makes a significant impact within the aims and scope of the journal, and which provides an important advancement in reader’s knowledge or understanding. Supporting data or additional experimental details can be submitted as Supplementary Information.

Format guide:
• Word limit: 3500 words (excluding the abstract and references).
• Key words (5-8 key words)
• References: 50
• Abstract: 300 words or less (Background, Methods, Results and Conclusions).
• Tables/Figures: Do not repeat the data extensively in tables or figures.

Brief Communications

Brief Communications are short manuscripts that have important and generally preliminary data on a specific issue.

Format guide:
• Word limit: 1700 words (excluding the abstract and references).
• References: 10-20.
• Abstract: Up to 75 words, unstructured
• Tables/Figures: 1 table and 2 figures.

Review Articles

Reviews are comprehensive or narrative appraisals of research in a particular field of current interest. Reviews highlight recent advances in research, current challenges and unmet needs. Authors are also encouraged to provide their perspective on current progress and future directions.

Format guide:
• Word limit: 4000 words (excluding the abstract and references).
• Key points should be reported on the title page in 50-words or less.
• References: unlimited.
• Abstract: Up to 200 words, unstructured.
•Tables/Figures: as necessary


Editorials are short articles that provide an insight into issues of topical importance to the journal’s target audience or researchers. The articles should provide an expert perspective on a topic of recent interest. This contribution is usually solicited by the Editors. If unsolicited, the authors are advised to contact our Editorial Team ( with an outline of the proposed review and CV of the authors.

Format guide:
• Word limit: 1400 words.
• Tables/Figures: A maximum of 1 figure or table.
• References: 15 or less.

Letters to the Editor

Letters to the Editor consists of comments on an articles published in Infect Dis Trop Med. Inclusion of Letters to the Editor in the journal is at the discretion of the Editor-in-Chief, and they may undergo external peer review. All Letters to the Editor will be subsequently sent to the author of the original article, who will have 60 days to provide a Reply to be published alongside the Letter.

Letters are restricted to the discussion of papers already published in the journal, with a maximum of 1,000 words, one table or figure and up to 20 references.

Case Quiz

Case Quiz are based on a question-and-answer format.

It usually illustrates an unusual disease or an atypical presentation of an infectious disease, to challenge the reader on its differential diagnosis.

The history of the case needs to be reported in the question portion of the article, but it should not disclose the diagnosis.

Format guide:
• Question should be written in a single paragraph.
• Figures: 3 or less.
• Answer should give the diagnosis and outline or include the key teaching points.

Short Reports and Case Reports (with or without accompanying Literature Review)

Case Reports present a notable medical case or series of related cases of particular interest to the field of regenerative medicine. Case Reports can be accompanied by a Review of the literature on the specific topic covered in the manuscript.

Format guide:

Word limit: 100

The abstract must not exceed 200 words.

Manuscript Submission

Authors should submit manuscripts, including supporting documents and figures to Publishing Manager.

Authors must submit manuscripts that are not published, in press, or submitted to other scientific journals, books or other venues that could be considered formal publication (including preprints). The correspondence for each article will be received by the Corresponding Author. The submission procedure requires a declaration of personal interests and funding interests of all authors; these details should also be included in the manuscript (see below).

Preprint Policy

Please note that IDTM does not accept submission of manuscripts that have previously been made available online as a preprint on a preprint server or on the authors’ own website.

Supporting Documents

Upon submission all manuscripts should include the following documents:

Authorship and Copyright

Authors must fulfill the following criteria:

  • He/she must have made a substantial contribution to research design, or to the acquisition, analysis or interpretation of data;
  • He/she must have drafted the paper or revised it critically;
  • He/she must have given approval of the submitted and final versions

Copyright Transfer Agreement: IDTM Authors will be required to sign a Copyright Transfer Agreement (click to download PDF) for all papers accepted for publication. Signature of the CTA is a condition of publication and papers will not be passed to the publisher for production unless a signed form has been received. After submission, Authors cannot submit their manuscripts to other journals. After acceptance, the Publisher got the rights and became the owner of the paper. To assist Authors, an appropriate CTA form will be supplied by the editorial office. The original completed Copyright Transfer Agreement must be signed by the corresponding Author and sent by e-mail to IDTM. The Editors retain the usual right to modify the style and length of a contribution (major changes being agreed with the corresponding Author) and to decide the time of publication.


To reproduce any third party material, such as figures or tables, authors must request, obtain and show permission from the copyright holder.

A statement indicating that permission has been obtained must be included in the relevant legend/footnote.



General Information:

The manuscript should be typed with a wide margin. Authors should retain one copy of all material, as the Editors cannot accept responsibility for loss of, or damage to, a manuscript.

The text should start with a structured Abstract, not exceeding 300 words, organized into sections using all of the following headings INTRODUCTION or BACKGROUND or OBJECTIVE, PATIENTS AND METHODS or MATERIALS AND METHODS, RESULTS, CONCLUSIONS.

Pages should be numbered consecutively in Arabic numerals, including tables, figure legends (with magnifications if needed), acknowledgments, and declaration of interests.

Abbreviations should be defined at the first use and should be kept to a minimum.

Language editing pre-submission: If English is not your first language, language editing is required before submission to ensure that the academic content of your paper is fully understood by journal editors and reviewers. Several editing companies offer such services.

References should be numbered in the order in which they are first mentioned in the text, and should be identified in the text, tables, and legends by Arabic numbers in superscript. List all the Authors. The US National Library of Medicine and used in Index Medicus applies (for more details see the section “References”). References must be verified by the Authors against the original documents.

Authors should observe the following guidelines.

  1. Do not attempt to make your output approximate or match the typeset page.
  2. Be consistent in style (i.e., units, abbreviations).
  3. End paragraphs in a uniform manner, and in a different manner from line endings within paragraphs. A frequently used paragraph ending is simply two carriage returns.
  4. Use double spacing in your document. Do not add extra line spacing (except as a normal paragraph ending indication) above or below titles, subheads, or between paragraphs.
  5. Avoid using multiple spaces (horizontal) in your electronic manuscript. End sentences with only one space. Never use multiple spaces for horizontal positioning of text.
  6. Tables and figure captions should be prepared in separate files. The authors have to indicate this material within the text.

Additional tables or figures and/or extra methodological detail can be included in a separate Supplementary Appendix.

Authors who want to publish in our Journal must follow the guidelines on Good Publication Practice as reported in COPE and Council of Science Editors. These guidelines aim to ensure that articles are published in a responsible and ethical manner.

Title page:

The Authors’ names, appointments and work address at the relevant time, plus the full contact details of the Corresponding Author including their current e-mail address must be reported.

A full and a short running title.

Key words for indexing purposes (5-10).


Original article 300 words (Introduction or Background, Patients and Methods or Materials and Methods, Results, and Conclusions).

Brief communication 75 words, unstructured.

Review 200 words, unstructured.


The paper should then proceed conventionally:

Introduction or Background or Objective

Materials and Methods or Patients and Methods





All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals.

When reporting the reference numbers in the text, you have to follow these rules: “1-2” must be written as “1,2” and so on. You have to put “-“ just in case you have many consecutive numbers. For example: “1,2,3,4,5,6” must be written as “1-6”;

References’ numbers must follow a chronological order within the text and must be inserted before the punctuation. (YES 12. NO.12)

Complete all the references in accordance with the Instructions for the authors (see How to submit an article, list all the authors (NOT et al), year without month of publication, delete the number of the single issue after the volume’s number, name of the journal: write the international acronyms without any punctuation; you must put a space after semicolon and colon (NOT 2014;2014:907915, YES 2014; 2014: 907915); moreover, initial and final pages must be entirely reported (NOT 135-46; YES 135-146). Delete the PMID and DOI number when you have the data aforementioned;

In the references, you must enter a space after semicolon and colon

  • YES: Garcia-Contreras M, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. Eur Rev Med Pharmacol Sci 2017; 21: 2940-2956.
  • NOT: Garcia-Contreras M, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. EurRevMedPharmacolSci 2017;21:2940-2956.

In the references, you must substitute “and” with “,” (comma) before the last author’s name;

In the references, all the authors must be written with the same character size. You must write only the first letter in capital letter, without change the size of them.

(NOT) Example 1: NAINAN OV, XIA G, VAUGHAN G, MARGOLIS HS. Diagnosis of hepatitis A virus infection: A molecular approach. Clinical Microbiology Reviews 2006:19:63-79.

(YES) Example 1: Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 2006; 19: 63-79.

(NOT) Example 2: Blyth I., Healy B., Nair S., Freedman A. Mycotic internal carotid artery aneurysm as a complication of recurrent Pseudomonas aeruginosa bacteraemia in a late-presenting HIV patient. Infectious Diseases & Tropical Medicine 2016;2(1):e235

(YES) Example 2: Blyth I, Healy B, Nair S, Freedman A. Mycotic internal carotid artery aneurysm as a complication of recurrent Pseudomonas aeruginosa bacteraemia in a late-presenting HIV patient. IDTM 2016; 2: e235.

Illustrations and Tables

Figure legends should be included in the main text of the manuscript and not form part of the figures. The authors are encouraged to send the highest-quality figures possible. For the accepted file format, see below:


Accepted File Formats

Document Files Graphic Files Graphic Files
• Word






• TIF (or TIFF)
• JPG (or JPEG)
• BMP 
• QuickTime
• AVI 


The figure resolution/specification for various types of original figures, at their final size, should be as follows: Line art – Minimum 600 dpi, measuring preferably 13 by 18 cm and no more than 20 by 25 cm in size. Halftone (i.e. both B/W and Colour photographs) – Minimum 300 dpi, measuring preferably 13 by 18 cm and no more than 20 by 25 cm in size. Line and tone (line art and halftone combined) – Minimum 600 dpi, measuring preferably 13 by 18 cm and no more than 20 by 25 cm in size.

For line figures, the lines should be solid, the text in a standard font and not blurred, and the overall image should be sharp and clear. Avoid using tints if possible; if they are essential to the understanding of the figure, try to make them coarse. As a guide, if the electronic files are viewed at 400% on the computer screen and they look blurred or pixelated in any way then they will NOT be of sufficient quality for printing.

Tables should be self-contained and complete; they must not duplicate the information already contained in the text. They should be supplied as editable files (preferably word files), not pasted as images. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for p-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure and table legends must be able to stand alone in the text and thus full descriptive legends for all figures and tables should be supplied.

Drug Names

Generic names should, in general, be used. If an Author desires, brand names may be inserted in parentheses. Drug names are spelled out according to the European Pharmacopoeia, but the American spelling should be used after the first use of a drug name.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see, where examples of acceptable nomenclature are provided.


Methods should be referenced. Two-tailed significance tests should be used unless explicitly stated. Controls should be described as completely as experimental subjects. Measures of location should be accompanied by measures of variability (e.g. mean and confidence intervals) as well as conventional probability values. Clinical trial reports should include the power of the study design.

Ethics, Institutional Review Boards and Informed Consent

Submitted clinical studies must include a reference to the appropriate Ethics Committee / Institutional Review Board (IRB) and have an appropriate Consent Form approved by the Ethics Committee / IRB before enrollment of the research subjects in the reported study. Appropriate review process and approval should be also documented for all pre-clinical experimental studies submitted. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Animal Ethics

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Should any questionable approval process emerge, the Editors reserve the right to reject any submitted paper.

Informed Consent

Appropriate consents, permissions and releases must be obtained where authors wish to include case details or other personal information or images of patients and any other individuals in their publication. This is to comply with all applicable laws and regulations concerning the privacy and/or security of personal information, including, but not limited to the General Data Protection Regulation (GDPR) (EU) 2016/679.

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.

The following statement should be included in each manuscript submitted to our journal:

Informed consent: Informed consent was obtained from all individual participants included in the study.

Some considerations

  • Images of patients or research subjects should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent.
  • If identifying characteristics are altered to protect anonymity, authors should provide assurances that such alterations do not distort scientific meaning.
  • Formal consents are not required for the use of entirely anonymized images from which the individual cannot be identified – for example, x-rays, ultrasound images, laparoscopic images etc.
  • If consent has not been obtained, it is generally not sufficient to anonymize a photograph simply by using eye bars or blurring the face of the individual concerned.

Plagiarism or other types of unethical publication practice

Authors who want to publish in our Journal must follow the guidelines on Good Publication Practice as reported in COPE and Council of Science Editors. These guidelines aim to ensure that articles are published in a responsible and ethical manner.

On a practical level, the first thing we do is conduct an early investigation using our anti‐plagiarism software. Our Journal makes a plagiarism checker by a certificate program on all the articles. Also, articles that are related to the suspected case of plagiarism or other unethical practice are checked accuracy by either the reviewer feedback and observations or the Editors own observations. Our anti‐plagiarism software, however, will not identify “salami slicing”. So it is imperative that each case is looked at individually and, therefore, we do not advocate the use of one statement of actions to penalize the offender. Each case is considered separately and, as editors, we will need to decide if it is a deliberate action on the part of the author or it is due to a lack of understanding of the requirements of ethical writing. This can happen for new authors or some authors where translation to English is often difficult. An example of this is where there are no words/phrases in that language that translate into English, and a developing practice that we noted is the ‘borrowing’ of words, phrases or often sentences that are considered appropriate for what authors mean to say.

IDTM disapproves any kind of malpractice and unethical practice.

Clinical trials

For reporting Clinical Trials Conducted by Pharmaceutical Companies Please ensure that clinical trials sponsored by pharmaceutical companies follow the guidelines on Good Publication Practice: and  These guidelines aim to ensure that such trials are published in a responsible and ethical manner. The guidelines cover companies’ responsibility to endeavor to publish results of all studies, companies’ relations with investigators, measures to prevent redundant or premature publication, methods to improve trial identification, and the role of professional medical writers. Moreover, authors are requested to register the clinical trial presented in the manuscript in a public trials registry and include the trial registration number at the end of the abstract.


All funding sources for the study should be reported in a separate section entitled “Funding.” This should appear before the “Acknowledgment” section.


Any assistance in preparing the manuscript should be stated. Personal acknowledgment should precede those of institutions of agencies.


Authors must fulfill the following criteria:

  • He/she must have made a substantial contribution to research design, or to the acquisition, analysis or interpretation of data;
  • He/she must have drafted the paper or revised it critically;
  • He/she must have given approval of the submitted and final versions.

Revised Articles

Revised articles must be submitted again within 2 months, or else will be considered as rejected.

Galley Proofs

The corresponding Author will receive an e-mail with a pdf file of the galley proof. The galley proof can be downloaded as a PDF (portable document format) file. Acrobat Reader will be required in order to read this file. This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Excessive changes (i.e. over 100 characters) made by the Author to the proofs, excluding typesetting errors, will be charged separately. Changes to figures and tables have an extra cost. Please check carefully the galley proof (especially for what concerns the name of Authors, affiliations and corresponding Authors) as after its approval no further change will be possible.

Before the publication, Infectious Diseases and Tropical Medicine sends the final galley proof in which only missed misstatements in the previous galley proof can be corrected.


Paper reprints shall be charged. Electronic offprints are sent to the first Author at his/her first email address on the title page of the paper, on request. For this reason, please ensure that the name, address and email address of the corresponding Author are clearly indicated on the manuscript title page if he/she is not the first author of the paper.


You can contact Our team will be able to provide advice and quotations for supplements.

Preservation and Archiving

Our Journal is committed to the permanent availability and preservation of scholarly research and to ensure accessibility by upgrading digital file formats to comply with new technology standards. All our files are archived and preserved in CLOCKSS.